Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening

New England Journal of Medicine

Volumn 341, Issue 12, 1999, Pages 866-870

  Vogt, Manfred ^a   Lang, Thomas ^b,c   Frösner, Gert ^b   Klingler, Christiane ^b   Sendl, Anna F ^b   Zeller, Anita ^b   Wiebecke, Baldur ^b   Langer, Barbara ^b   Meisner, Hans ^a   Hess, John ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; CHILD; CONTROLLED STUDY; FEMALE; HEART SURGERY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFANT; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; VIRUS TRANSMISSION;

ADULT; BLOOD DONORS; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INFANT; LIVER FUNCTION TESTS; MALE; PREVALENCE; RISK FACTORS; RNA, VIRAL;

EID: 0033576001     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199909163411202     Document Type: Article

References (36)

1. Chung JL, Kao JH, Kong MS, Yang CP, Hung IJ, Lin TY. Hepatitis C and G virus infections in polytransfused children. Eur J Pediatr 1997;156: 546-9.
2. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;334:1691-6.
3. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-90.
4. Tobler LH, Busch MP. History of posttransfusion hepatitis. Clin Chem 1997;43:1487-93.
5. Arico M, Maggiore G, Silini E, et al. Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 1994;84:2919-22.
6. Locasciulli A, Testa M, Pontisso P, et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 1997;90:4628-33.
7. Tada K, Tajiri H, Kozaiwa K, Sawada A, Guo W, Okada S. Role of screening for hepatitis C virus in children with malignant disease and who undergo bone marrow transplantation. Transfusion 1997;37:641-4.
8. Cesaro S, Petris MG, Rossetti F, et al. Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 1997;90:1315-20.
9. Nelson SP, Jonas MM. Hepatitis C infection in children who received extracorporeal membrane oxygenation. J Pediatr Surg 1996;31:644-8.
10. Jonas MM, Baron MJ, Bresee JS, Schneider LC. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin. Pediatrics 1998;98:211-5.
11. Misra S, Ament ME, Vargas JH, Skoff C, Reyen L, Herzog F. Chronic liver disease in children on long-term parenteral nutrition. J Gastroenterol Hepatol 1996;11:S4-S6.
12. Resti M, Azzari C, Rossi ME, Vullo C, Zammarchi E, Vierucci A. Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A non-B hepatitis. Eur J Pediatr 1992; 151:573-6.
13. Takahashi M, Yamada G, Tsuji T. Intrafamilial transmission of hepatitis C. Gastroenterol Jpn 1991;26:483-8.
14. Bortolotti F, Resti M, Giacchino R, et al. Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. J Pediatr 1997;130:990-3.
15. Sasaki N, Matsui A, Momoi M, Tsuda F, Okamoto H. Loss of circulating hepatitis C virus in children who developed a persistent carrier state after mother-to-baby transmission. Pediatr Res 1997;42:263-7.
16. Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lancet 1995;345:289-91.
17. Gish RG, Cox KL, Mizokami M, Ohno T, Lau JYN. Vertical transmission of hepatitis C. J Pediatr Gastroenterol Nutr 1996;22:118-9.
18. Kage M, Fujisawa T, Shiraki K, et al. Pathology of chronic hepatitis C in children. Hepatology 1997;26:771-5.
19. Badizadegan K, Jonas MM, Ott MJ, Nelson SP, Perez-Atayde AR. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998;28:1416-23.
20. Matsuoka S, Tatara K, Hayabuchi Y, Nii M, Mori K, Kuroda Y. Posttransfusion chronic hepatitis C in children. J Paediatr Child Health 1994; 30:544-6.
21. Schlebusch H, Rick W, Lang M, Knedel M. Normbereiche der Aktivitäten klinisch wichtiger Enzyme. Dtsch Med Wochenschr 1974;99:765-6.
22. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
23. Pocock SJ. Clinical trials: a practical approach. Chichester, England: John Wiley, 1983.
24. Darby SC, Ewart DW, Giangrande PLF, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997;350:1425-31.
25. Fujisawa T, Komatsu H, Inui A, et al. Spontaneous remission of chronic hepatitis C in children. Eur J Pediatr 1997;156:773-6.
26. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-6.
27. Mathurin P, Moussalli J, Cadranel JF, et al. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology 1998;27:868-72.
28. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-56.
29. Lau DTY, Kleiner DE, Ghany MG, Park Y, Schmid P, Hoofnagle JH. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. Hepatology 1998;28:1121-7.
30. Serfaty L, Chazouilleres O, Pawlotsky JM, Andreani T, Pellet C, Poupon R. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology 1996;110:291-5.
31. Matsuoka S, Mori K, Nakano O, et al. Efficacy of interferons in treating children with chronic hepatitis C. Eur J Pediatr 1997;156:704-8.
32. Poynard T, Bedossa P, Chevallier M, et al. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995;332:1457-62. [Erratum, N Engl J Med 1996;334:1143.]
33. Davis GL, Balart LA, Schiff ER, et al. Treatment of chrome hepatitis C with recombinant interferon alfa. N Engl J Med 1989;321:1501-6.
34. Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon alfa therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial. N Engl J Med 1989;321:1506-10.
35. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-92.
36. Poynard T, Marcellin P, Lee SS, et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998;352:1426-32.